Role of the CMC Regulatory Strategist in Due Diligence

Posted 01 July 2009 | By

A pharmaceutical or biologic due diligence exercise is a matchmaking process between two companies. It is undertaken to explore a potential deal driven by one company's need for another's medicinal product, medical device or technology, or in some cases, the other company in its entirety.

Categories:

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe